If we can understand what cell types and proteins are critically important in chronic-inflammation-driven tumor formation and stem cell exhaustion, we can potentially design better and safer drugs to intervene.Funding for the research outlined in the eLIFE paper, titled MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice, was provided by the Nation